vs
Side-by-side financial comparison of Plymouth Industrial REIT, Inc. (PLYM) and Vanda Pharmaceuticals Inc. (VNDA). Click either name above to swap in a different company.
Vanda Pharmaceuticals Inc. is the larger business by last-quarter revenue ($57.2M vs $51.2M, roughly 1.1× Plymouth Industrial REIT, Inc.). Plymouth Industrial REIT, Inc. runs the higher net margin — -106.3% vs -246.8%, a 140.5% gap on every dollar of revenue. On growth, Vanda Pharmaceuticals Inc. posted the faster year-over-year revenue change (7.6% vs -1.4%). Over the past eight quarters, Vanda Pharmaceuticals Inc.'s revenue compounded faster (9.8% CAGR vs 0.4%).
Plymouth Industrial REIT, Inc. is a real estate investment trust focused on owning, operating, and acquiring high-quality industrial properties including distribution centers, warehouses, and light industrial facilities across key U.S. logistics hubs. It serves tenants in e-commerce, retail, manufacturing, and third-party logistics sectors, supporting diverse business supply chain needs.
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for central nervous system disorders. Its key marketed products cover indications including sleep-wake cycle disturbances and schizophrenia, with core operations and primary sales markets concentrated in North America, catering to patient groups with significant unmet medical needs.
PLYM vs VNDA — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $51.2M | $57.2M |
| Net Profit | $-54.4M | $-141.2M |
| Gross Margin | — | — |
| Operating Margin | -102.5% | -70.5% |
| Net Margin | -106.3% | -246.8% |
| Revenue YoY | -1.4% | 7.6% |
| Net Profit YoY | -248.5% | -2774.3% |
| EPS (diluted) | $-1.23 | $-2.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $57.2M | ||
| Q3 25 | $51.2M | $56.3M | ||
| Q2 25 | $47.2M | $52.6M | ||
| Q1 25 | $45.6M | $50.0M | ||
| Q4 24 | $47.6M | $53.2M | ||
| Q3 24 | $51.9M | $47.7M | ||
| Q2 24 | $48.7M | $50.5M | ||
| Q1 24 | $50.2M | $47.5M |
| Q4 25 | — | $-141.2M | ||
| Q3 25 | $-54.4M | $-22.6M | ||
| Q2 25 | $-6.1M | $-27.2M | ||
| Q1 25 | $5.8M | $-29.5M | ||
| Q4 24 | $147.4M | $-4.9M | ||
| Q3 24 | $-15.6M | $-5.3M | ||
| Q2 24 | $1.3M | $-4.5M | ||
| Q1 24 | $6.2M | $-4.1M |
| Q4 25 | — | -70.5% | ||
| Q3 25 | -102.5% | -55.6% | ||
| Q2 25 | -10.3% | -73.2% | ||
| Q1 25 | — | -82.0% | ||
| Q4 24 | — | -19.3% | ||
| Q3 24 | -29.6% | -23.1% | ||
| Q2 24 | 2.7% | -20.1% | ||
| Q1 24 | — | -19.5% |
| Q4 25 | — | -246.8% | ||
| Q3 25 | -106.3% | -40.1% | ||
| Q2 25 | -12.9% | -51.7% | ||
| Q1 25 | 12.8% | -58.9% | ||
| Q4 24 | 309.9% | -9.2% | ||
| Q3 24 | -30.1% | -11.2% | ||
| Q2 24 | 2.7% | -9.0% | ||
| Q1 24 | 12.4% | -8.7% |
| Q4 25 | — | $-2.40 | ||
| Q3 25 | $-1.23 | $-0.38 | ||
| Q2 25 | $-0.14 | $-0.46 | ||
| Q1 25 | $0.13 | $-0.50 | ||
| Q4 24 | $3.24 | $-0.09 | ||
| Q3 24 | $-0.35 | $-0.09 | ||
| Q2 24 | $0.03 | $-0.08 | ||
| Q1 24 | $0.14 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $84.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $470.1M | $327.2M |
| Total Assets | $1.6B | $488.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $84.9M | ||
| Q3 25 | — | $70.0M | ||
| Q2 25 | — | $81.0M | ||
| Q1 25 | — | $111.8M | ||
| Q4 24 | — | $102.3M | ||
| Q3 24 | — | $100.5M | ||
| Q2 24 | — | $103.0M | ||
| Q1 24 | — | $125.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $646.4M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $327.2M | ||
| Q3 25 | $470.1M | $466.0M | ||
| Q2 25 | $539.6M | $486.3M | ||
| Q1 25 | $571.0M | $511.4M | ||
| Q4 24 | $579.5M | $538.5M | ||
| Q3 24 | $436.5M | $541.2M | ||
| Q2 24 | $475.2M | $542.5M | ||
| Q1 24 | $484.6M | $544.0M |
| Q4 25 | — | $488.9M | ||
| Q3 25 | $1.6B | $601.1M | ||
| Q2 25 | $1.6B | $624.7M | ||
| Q1 25 | $1.4B | $631.9M | ||
| Q4 24 | $1.4B | $656.2M | ||
| Q3 24 | $1.5B | $645.1M | ||
| Q2 24 | $1.4B | $651.4M | ||
| Q1 24 | $1.4B | $652.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.12× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $20.0M | $-29.4M |
| Free Cash FlowOCF − Capex | — | $-29.5M |
| FCF MarginFCF / Revenue | — | -51.6% |
| Capex IntensityCapex / Revenue | — | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-110.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-29.4M | ||
| Q3 25 | $20.0M | $-31.6M | ||
| Q2 25 | $23.4M | $-15.3M | ||
| Q1 25 | $15.6M | $-33.1M | ||
| Q4 24 | $96.1M | $-1.8M | ||
| Q3 24 | $17.6M | $-14.6M | ||
| Q2 24 | $19.9M | $-6.9M | ||
| Q1 24 | $16.6M | $7.6M |
| Q4 25 | — | $-29.5M | ||
| Q3 25 | — | $-31.8M | ||
| Q2 25 | — | $-15.6M | ||
| Q1 25 | — | $-33.6M | ||
| Q4 24 | — | $-2.0M | ||
| Q3 24 | — | $-14.7M | ||
| Q2 24 | — | $-7.0M | ||
| Q1 24 | — | $7.6M |
| Q4 25 | — | -51.6% | ||
| Q3 25 | — | -56.5% | ||
| Q2 25 | — | -29.6% | ||
| Q1 25 | — | -67.1% | ||
| Q4 24 | — | -3.8% | ||
| Q3 24 | — | -30.9% | ||
| Q2 24 | — | -13.9% | ||
| Q1 24 | — | 15.9% |
| Q4 25 | — | 0.2% | ||
| Q3 25 | — | 0.3% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | 0.9% | ||
| Q4 24 | — | 0.4% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 2.67× | — | ||
| Q4 24 | 0.65× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 15.12× | — | ||
| Q1 24 | 2.67× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PLYM
Segment breakdown not available.
VNDA
| Fanapt | $33.2M | 58% |
| Hetlioz | $16.4M | 29% |
| PONVORY | $7.6M | 13% |
